Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05056402Phase 3Active Not Recruiting
An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old
Cervical CancerCondylomata Acuminata
PrincipalinvestigatorStart date: 2021-09-19

Research Network

Collaboration Network

14 collaborators·13 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Sichuan Provincial Centre for Disease Control and Prevention

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jun Zhang, master

Xiamen University

Related
12 trials

Shared therapeutic areas:

Condylomata AcuminataCancer of the Uterine Cervix

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Xiamen Innovax Biotech Co., Ltd+1 more
Collaborated on 1 trial
Similarity Score24%

Juntao Ran

LanZhou University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Xiaojie Ma

Affiliated Hospital of North Sichuan Medical College

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Xiaoying Xue

The Second Hospital of Hebei Medical University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Kun Gao

Guangxi Medical University Cancer Center

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Dapeng Li

Shandong Cancer Hospital & Institute

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Sandro Pignata, M.D., Ph.D.

National Cancer Institute, Naples

Related
9 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05056402Phase 3PrincipalInvestigator

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Cervical CancerCondylomata Acuminata
Active Not Recruiting

All 1 trials loaded